DTL
PLRX icon

Dynamic Technology Lab’s Pliant Therapeutics PLRX Stock Holding History

Dynamic Technology Lab’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,487
Closed -$188K – 1270
2024
Q2 		$188K Buy
+17,487
New +$225K 0.02% 809
2023
Q1 		– Sell
-11,726
Closed -$227K – 1424
2022
Q4 		$227K Buy
+11,726
New +$245K 0.02% 874

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Dynamic Technology Lab's PLRX Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Pliant Therapeutics (PLRX) in Q3 2024, closing a stake of 17,487 shares — an estimated $188K sold.

Dynamic Technology Lab first reported a position in PLRX in Q4 2022 and held it in 2 quarters. The position peaked at $227K in Q4 2022. 151 funds tracked by Wall St. Rank hold PLRX as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Pliant Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,487 Pliant Therapeutics shares in Q3 2024, an estimated $188K.
  • Dynamic Technology Lab first reported a position in Pliant Therapeutics in Q4 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's Pliant Therapeutics position peaked at $227K in Q4 2022.
  • 151 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.